{"id":1010,"date":"2023-01-03T10:41:53","date_gmt":"2023-01-03T15:41:53","guid":{"rendered":"https:\/\/health.uconn.edu\/molecular-oncology\/?page_id=1010"},"modified":"2023-08-18T13:51:58","modified_gmt":"2023-08-18T17:51:58","slug":"2019-2020-seminars","status":"publish","type":"page","link":"https:\/\/health.uconn.edu\/molecular-oncology\/seminars\/2019-2020-seminars\/","title":{"rendered":"2019-2020 Seminars"},"content":{"rendered":"<p><strong>September 23, 2020<\/strong><br \/>\nTitle: Genetic Changes Thyroid Cancer: Evolution Toward Predictive and Therapeutic Targeting<br \/>\nSpeaker: Matthew Ringel, M.D., Ohio State University, Columbus, OH<\/p>\n<p><strong>November 18 , 2019<\/strong><br \/>\nTitle: Unique targeting of metastasis and tumor suppressors by clinically-trialed, innovative anti-cancer agents that inhibit multiple oncogenic signaling pathways<br \/>\nSpeaker: Des R. Richardson, Ph.D., University of Sydney, Camperdown, Australia<\/p>\n<p><strong>November 6, 2019<\/strong><br \/>\nTitle: Epigenetics in Hematopoiesis and Leukemia: The Role of the PAF1 Complex<br \/>\nSpeaker: Andrew Muntean, Ph.D., University of Michigan, Ann Arbor, MI<\/p>\n<p><strong>February 27, 2019<\/strong><br \/>\nTitle: Regulation of miRNA in breast cancer by methylation reader HNRNPA2B1<br \/>\nSpeaker: Carolyn Klinge, Ph.D., University of Louisville, Louisville, KY<\/p>\n<p><strong>April 10, 2019<\/strong><br \/>\nTitle: Microbial sulfur metabolism and colorectal cancer risk<br \/>\nSpeaker: H. Rex Gaskins, Ph.D., University of Illinois, Urbana, IL<\/p>\n<p><strong>October 2, 2019<\/strong><br \/>\nTitle: Bench to Bed and Back: Early Clinical Trails<b><br \/>\n<\/b> Speaker: Patricia LoRusso, D.O., Ph.D., Yale University, New Haven, CT<\/p>\n","protected":false},"excerpt":{"rendered":"<p>September 23, 2020 Title: Genetic Changes Thyroid Cancer: Evolution Toward Predictive and Therapeutic Targeting Speaker: Matthew Ringel, M.D., Ohio State University, Columbus, OH November 18 , 2019 Title: Unique targeting of metastasis and tumor suppressors by clinically-trialed, innovative anti-cancer agents that inhibit multiple oncogenic signaling pathways Speaker: Des R. Richardson, Ph.D., University of Sydney, Camperdown, [&hellip;]<\/p>\n","protected":false},"author":2565,"featured_media":0,"parent":90,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-23 05:29:10","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/pages\/1010"}],"collection":[{"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/users\/2565"}],"replies":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/comments?post=1010"}],"version-history":[{"count":1,"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/pages\/1010\/revisions"}],"predecessor-version":[{"id":1011,"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/pages\/1010\/revisions\/1011"}],"up":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/pages\/90"}],"wp:attachment":[{"href":"https:\/\/health.uconn.edu\/molecular-oncology\/wp-json\/wp\/v2\/media?parent=1010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}